Related Experiment Video
Updated: Aug 5, 2026
08:04
Murine Fetal Echocardiography
Published on: February 15, 2013
Fetal organ dose calculator for maternal CT
Sergio Morató1, Yeon Soo Yeom2, Les R Folio3
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.
Medical Physics
|July 29, 2026
Summary
Accurate fetal dose estimation during pregnancy CT scans is now possible with NCICT3.0, utilizing detailed computational models. This advanced system provides organ-specific dose calculations, improving safety and research for maternal CT imaging.
Area of Science:
- Medical Physics
- Radiological Sciences
- Computational Biology
Background:
- Computed tomography (CT) is crucial for diagnosing urgent conditions in pregnant patients.
- Accurate fetal dose estimation remains a challenge, with prior methods lacking organ-specific detail.
- Existing models often use simplified uterus dose or fetal representations.
Purpose of the Study:
- To develop NCICT3.0 by integrating detailed pregnant woman and fetus computational phantoms.
- To calculate fetal organ dose coefficients for maternal chest and abdomen-pelvis CT scans.
- To validate phantom-based estimates against patient-specific CT-based Monte Carlo simulations.
Main Methods:
- Utilized computational phantoms (8-38 weeks gestation, cephalic/breech presentations) in Monte Carlo simulations.
- Calculated fetal organ dose coefficients using MCNPX for various CT scan conditions.
- Modeled longitudinal tube current modulation (TCM) and compared phantom doses with patient-specific simulations (MCGPU).
Main Results:
- Generated comprehensive fetal organ dose coefficients in NCICT3.0, showing significant variability.
- Fetal doses in chest CT increased with gestational age; abdomen-pelvis CT doses decreased with age.
- Maternal uterus dose underestimated fetal organ doses; TCM reduced fetal doses, especially in early gestation.
Conclusions:
- NCICT3.0 offers a comprehensive fetal organ-level dose library for CT imaging.
- Enables organ-specific dose estimation, supporting research on dose heterogeneity and risk modeling.
- Aids in optimizing maternal CT imaging protocols for improved fetal safety.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:30Radiological Investigation I: X-ray and CT
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and the...